Aarhus University Seal / Aarhus Universitets segl

Sussie Antonsen

Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Department of Clinical Epidemiology
Preliminary evidence suggests that metformin may decrease breast cancer risk by decreasing insulin levels and reducing cell proliferation. We evaluated the effect of metformin medication on the risk of incident breast cancer among peri- and postmenopausal women.
Original languageEnglish
JournalCancer Epidemiology, Biomarkers & Prevention
Pages (from-to)101-11
Number of pages11
Publication statusPublished - 1 Jan 2011

See relations at Aarhus University Citationformats

ID: 35257666